Biotron Limited develops drugs for viral diseases with unmet medical needs, including BIT225 for HIV-1 and a preclinical program for HBV. The Company also targets viroporins, viral proteins key to viruses like Dengue, Ebola, MERS, Influenza, and Zika. Now expanding into anaesthesia & neuroscience with SedRxâ„¢, a next-generation general anaesthetic with superior safety and cognitive outcomes.
| Website | https://www.biotron.com.au/ |
| Employees | 6 (3 on RocketReach) |
| Address | 66 Hunter St, Level 2, Sydney, New South Wales 2000, AU |
| Phone | +61 2 9805 0488 |
| Industry | Biotechnology Research |
Looking for a particular Biotron Limited employee's phone or email?
Michelle Miller is the CEO and MD of Biotron Limited.
3 people are employed at Biotron Limited.
Biotron Limited is based in Sydney, New South Wales.